novo nordisk lawsuit semaglutide A Review of Nordisk's Ozempic and Wegovy Trademark Enforcement Campaign Novo Nordisk takes legal action

Discontinue Zepbound if suspected and promptly seek medical advice

The era of easy arbitrage is over

This instability underscores one of the risks associated with depending on compounded medications for weight loss

WATCH | WHO recommends GLP-1 therapies for obesity: Health Canada has also listed known risks associated with the use of genuine GLP-1 products, including severe gastrointestinal problems, pancreatitis, worsening kidney injury and low blood sugar, particularly if combined with other medications

Further information is available from the NHS, NICE, and the MHRA

What do retatrutide before and after results look like